Spirair provides minimally invasive, bioabsorbable implant systems for otolaryngologists to treat nasal obstruction. Its SeptAlign implant mechanically corrects minor septal deviation, while TurbAlign medializes the middle turbinate, both using a single‑pass, knot‑free delivery that reduces operative time, eliminates extensive dissection, and resorbs as tissue heals, delivering faster recovery and improved airflow.
Funding
$12.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with nasal obstruction due to deviated septum or enlarged turbinates often require invasive surgical procedures that involve extensive tissue manipulation, long recovery times, and significant postoperative discomfort. Traditional techniques can be technically demanding and may not integrate easily into routine ENT practice, limiting access to effective treatment for many sufferers.
Solution
Spirair offers minimally invasive, bioabsorbable implant systems designed to correct minor nasal septum deviation (SeptAlign) and medialize the middle turbinate (TurbAlign). The devices are delivered through a simple, one‑pass placement technique that avoids sutures or extensive dissection, reducing operative time and postoperative recovery. The implants provide mechanical support while gradually resorbing as the tissue heals, maintaining airway patency without permanent foreign material. By integrating easily into existing ENT treatment algorithms, these solutions enable clinicians to treat a broader range of nasal obstruction patients with less morbidity and faster return to normal activities.
Target Audience
Primary customers are otolaryngologists and facial plastic surgeons who treat nasal obstruction and seek minimally invasive alternatives to conventional septoplasty and turbinate reduction procedures.
Features
- SeptAlign: bioabsorbable implant that mechanically corrects minor nasal septum deviation without the need for traditional septoplasty incisions
- TurbAlign: single‑pass, knot‑free delivery system for reliable middle turbinate medialization
- Resorbable polymer material that provides structural support during healing and fully degrades thereafter
- Simplified procedure workflow that reduces operative time and eliminates the need for extensive suturing or grafting
- Designed for use in standard ENT office or operating room settings, compatible with existing instrumentation
- Maintains open nasal cavity and improves airflow with minimal postoperative discomfort